Special brain scans to help guide tube placement in glioma surgery
Original title: Multiparametric Metabolic and Hypoxic PET/MRI Imaging Substudy in Gliomas
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a very early test in a small number of people.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests whether new scans can help doctors place treatment tubes in the brain.
Who this trial is for. This substudy is for 20 adults with malignant gliomas, a type of brain tumor. They are already taking part in a main study of pembrolizumab and M032. It tests PET and MR scans that use two research drugs, called [18F]FET and [18F]FMISO.
Where it stands. This trial has not reported results. It is looking at whether the scan pictures help doctors decide where to place the tubes that deliver therapy during brain surgery. The answer is not in yet.
What this means, and what it doesn't
What it could mean: For now, this is a test of an imaging method, not care your own doctor can give you. Someone who fits the main study and wants to know more could ask their care team about it.
What it doesn't mean: This does not mean the scans or the treatment are proven. A trial is a test, not an approved treatment. Joining one is not a guarantee that it will help you. It is not a promise of a cure. Whether anyone can take part is decided by the trial team.
Source: ClinicalTrials.gov, August 21, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.